Aubagio and Tenormin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aubagio (teriflunomide) and Tenormin (atenolol). Common drug interactions include alopecia among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Aubagio and Tenormin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Aubagio?

Aubagio has active ingredients of teriflunomide. It is often used in multiple sclerosis. eHealthMe is studying from 50,041 Aubagio users. Check the latest studies of Aubagio.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,474 Tenormin users. Check the latest studies of Tenormin.

On Jul, 24, 2026

14 people who take Aubagio and Tenormin together, and have interactions are studied.

What are the common drug interactions of Aubagio and Tenormin, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Abasia (inability to walk)
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Burning sensation
Concussion (short loss of normal brain function in response to a head injury)

male:

Back pain
Dysstasia (difficulty in standing)
Muscle spasms (muscle contraction)
Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Influenza like illness
Epidural lipomatosis (excessive accumulation of fat within the epidural space -brain)
Fall
Limb discomfort (discomfort in leg)
Mobility decreased (ability to move is reduced)

What are the common drug interactions of Aubagio and Tenormin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gastric bypass
Stress

50-59:

Back pain
Fall
Dysstasia (difficulty in standing)
Epidural lipomatosis (excessive accumulation of fat within the epidural space -brain)
Fatigue (feeling of tiredness)
Limb discomfort (discomfort in leg)
Mobility decreased (ability to move is reduced)
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases)

60+:

Hypoaesthesia (reduced sense of touch or sensation)
Abasia (inability to walk)
Pain
Urinary tract infection
Angina pectoris (chest pain due to ischemia of the heart muscle)
Asthenia (weakness)
Blindness unilateral
Blood potassium decreased
Breast cancer
Confusional state

What are the existing conditions these people have? *

Gait Disturbance: 4 people, 28.57%
Depression: 3 people, 21.43%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 14.29%
Diabetes: 2 people, 14.29%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Hypoaesthesia (reduced sense of touch or sensation): 2 people, 14.29%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Aubagio and Tenormin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously